370P Bespoke circulating tumour DNA assay for the detection of minimal residual disease in esophageal adenocarcinoma patients

Autor: H.-T. Wu, A. Redmond, Himanshu Sethi, Ginny Devonshire, Bernhard Zimmermann, N. Grehan, Alexey Aleshin, Scott Dashner, A. Ng, E. Ococks, Rebecca C. Fitzgerald, W-C. Chan, Shruti Sharma, A. Northrop, Elizabeth C Smyth

Publikováno v: Annals of Oncology. 31:S1317-S1318

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e48ed5b458f7946e79c20a302fa435e6
https://doi.org/10.1016/j.annonc.2020.10.594

Assessing the clinical utility of circulating tumour DNA through longitudinal liquid biopsy sampling in oesophageal adenocarcinoma

Autor: Christopher C.W. Hughes, Rebecca C. Fitzgerald, A. Frankell, Elizabeth C Smyth, E. Ococks, Ginny Devonshire, Nicola Grehan, A. Northrop, Adrienn Blasko, N. Masque-Soler

Publikováno v: Annals of Oncology. 30:v315

Background Oesophageal cancer is the eighth most frequently diagnosed form of cancer and has a dismal 5-year survival rate of 12%, with Oesophageal adenocarcinoma (OAC) being the most common sub-type in western countries (Ferlay et al., 2012). Previo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ea87c8382f5ade77a87e56c0cb3c9379
https://doi.org/10.1093/annonc/mdz247.148

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Understanding the malignant potential of gastric metaplasia of the oesophagus and its relevance to Barrett's oesophagus surveillance: individual-level data analysis.

Autor: Black EL; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Ococks E; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Devonshire G; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Ng AWT; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., O'Donovan M; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Malhotra S; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Tripathi M; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Miremadi A; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Freeman A; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Coles H; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Fitzgerald RC; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK rcf29@cam.ac.uk.

Publikováno v: Gut [Gut] 2024 Apr 05; Vol. 73 (5), pp. 729-740. Date of Electronic Publication: 2024 Apr 05.